The Food and Drug Administration (FDA or the Agency) is announcing a public hearing on FDA's approach to enhancing competition and innovation in the biological products marketplace, including by facilitating greater availability of biosimilar and interchangeable products.
Document
Facilitating Competition and Innovation in the Biological Products Marketplace; Public Hearing; Request for Comments
The Food and Drug Administration (FDA or the Agency) is announcing a public hearing on FDA's approach to enhancing competition and innovation in the biological products marketpl...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 35154
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Facilitating Competition and Innovation in the Biological Products Marketplace; Public Hearing; Request for Comments,” thefederalregister.org (July 25, 2018), https://thefederalregister.org/documents/2018-15859/facilitating-competition-and-innovation-in-the-biological-products-marketplace-public-hearing-request-for-comments.